Mycetoma medical records study
Part of Infections, Skin clinical trials.
This study looks back at medical records of people diagnosed with mycetoma. It aims to collect data to better understand this rare infection, which could help improve future diagnosis and treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been diagnosed with mycetoma (a rare infection that can affect skin, muscle, and bone).
- Your medical, X-ray, or lab records must show the diagnosis.
- Your records must be readable and available for the research team.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks back at past medical records of people diagnosed with uveal melanoma. It helps researchers learn about the typical course of the disease by analyzing what already happened in care.
This study looks for specific lab “biomarkers” in people with mucormycosis, a serious fungal infection. It compares results with people who have higher infection risk but no active infection, to help doctors diagnose and track this illness more accurately.
This study looks at how immune system problems relate to fungal infections, using medical records and lab tests on blood and tissue. It may help researchers understand the cause of these infections—especially for people with inherited immune conditions—and improve future care.
This study gathers samples and data from cancer patients who have certain infections (like mucormycosis or aspergillosis) or are at risk for fungal infections. The goal is to better understand how to diagnose and treat these infections.
This study looks for causes of fungal ear infections (otomycosis) by comparing people with active infections to those without ear symptoms. You may join if you have ear symptoms and a confirmed fungal infection in your ear canal.
This is a study that collects information from people diagnosed with multiple myeloma. It may help researchers understand the disease and improve future care by using past and ongoing patient data.
Hear when a new Mycetoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.